AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Pharma)
M2PHARMA-March 21, 2012-Ampio strengthens patent protection for Ampion with notice of allowance from patent office (C)2012 M2 COMMUNICATIONS http://www.m2.com
Biopharmaceutical company Ampio Pharmaceuticals Inc (Nasdaq: AMPE) said on Tuesday that it has received a notice of allowance from the US Patent Office of an additional patent that complements and expands its anti inflammatory patent portfolio for its lead drug Ampion.
The company said that the allowed claims in this new patent protect pharmaceutical composition, includes the use of the low molecular weight fraction of commercially available (approved) human …